Beranda › Kanker Ginjal
Uji klinis Kanker Ginjal yang merekrut di AS
59 studi untuk Kanker Ginjal merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- New York City, NY15 studi
- Nashville, TN12 studi
- Boston, MA12 studi
- Houston, TX10 studi
- San Diego, CA9 studi
- Dallas, TX9 studi
- Washington, DC9 studi
- St. Louis, MO9 studi
- Edison, NJ8 studi
- Seattle, WA8 studi
- Rochester, MN7 studi
- Baltimore, MD7 studi
- Jacksonville, FL7 studi
- Miami, FL7 studi
- Los Angeles, CA7 studi
- Mountain View, CA6 studi
- Omaha, NE6 studi
- Durham, NC6 studi
- Aurora, CO6 studi
- Baldwin Park, CA6 studi
- Queens, NY6 studi
- Phoenix, AZ5 studi
- Pittsburgh, PA5 studi
- Cleveland, OH5 studi
- Columbus, OH5 studi
- New Rochelle, NY5 studi
- Staten Island, NY5 studi
- New Haven, CT4 studi
- Atlanta, GA4 studi
- Portland, OR4 studi
- Louisville, KY4 studi
- Highlands Ranch, CO4 studi
- Detroit, MI4 studi
- San Francisco, CA4 studi
- Orange, CA4 studi
- Denver, CO4 studi
- East Norwalk, CT4 studi
- San Antonio, TX4 studi
- Sacramento, CA3 studi
- Orlando, FL3 studi
Berdasarkan negara bagian
- Arizona8 studi
- Arkansas3 studi
- California19 studi
- Colorado9 studi
- Connecticut6 studi
- Florida14 studi
- Georgia6 studi
- Illinois7 studi
- Indiana4 studi
- Iowa4 studi
- Kentucky4 studi
- Louisiana3 studi
- Maryland16 studi
- Massachusetts14 studi
- Michigan6 studi
- Minnesota10 studi
- Missouri10 studi
- Nebraska6 studi
- New Jersey8 studi
- New York17 studi
- North Carolina8 studi
- Ohio10 studi
- Oklahoma4 studi
- Oregon4 studi
- Pennsylvania10 studi
- South Carolina5 studi
- Tennessee12 studi
- Texas18 studi
- Virginia6 studi
- Washington8 studi
- Wisconsin6 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
Hereditary Leiomyomatosis Renal Cell Cancer - Study of the Genetic Cause and the Predisposition to Renal Cancer
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 2 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT00050752Distance-Based Exercise to Preserve Function and Prevent Disability
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07059884Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies
Menerima pesertaStudi observasionalSukarelawan sehat diterima
4 Weeks · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT01109394[212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers
Menerima pesertaFase 1
Usia 18 hingga 120 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06479811A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06234605Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT05287945Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 2 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT00026884Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT07011719Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney Cancer
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 2 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT00033137Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT04981119A Phase 1b Study of HC-7366, an Agonist of ISR With Immunotherapy in Kidney Cancer (SHARK)
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07401875NSAID Use After Robotic Partial Nephrectomy
Menerima pesertaFase 2
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT05842044Photodynamic Diagnosis of Upper Tract Urothelial Carcinoma Using Fluorescence Endoscopy and Oral 5-ALA
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT06948552Photodynamic Diagnosis of Kidney Cancer Using Fluorescence Endoscopy and Oral 5-ALA
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT07828704A Study of Theranostic Pair PD-32766D/T in Participants With Carbonic Anhydrase IX Positive Clear Cell Renal Cell Carcinoma
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT07688187Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT07227415Patient Navigation Program to Improve Clinical Trial Enrollment in Cancer Patients
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT06138067A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 31 Agu 2026 · NCT05536141Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 2 ke atas · Semua jenis kelamin · Diperbarui 24 Agu 2026 · NCT00001238A Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell Carcinoma
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Agu 2026 · NCT07123090A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Agu 2026 · NCT07195682Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Agu 2026 · NCT07300241Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Agu 2026 · NCT05433142A Study of a Side Effects and Resource Navigation Program for People With Cancer
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 31 Jul 2026 · NCT07646847Palbociclib and Sasanlimab for the Treatment of Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Papillary Renal Cell Carcinoma (pRCC)
Menerima pesertaFase 1/2
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 29 Jul 2026 · NCT05665361Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.